Cargando…

Response to “Cytomegalovirus Enterocolitis in a Patient with Refractory Immune-Related Colitis”

Detalles Bibliográficos
Autores principales:	van Turenhout, Sietze, Snaebjornsson, Petur, van Dieren, Jolanda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7879246/ https://www.ncbi.nlm.nih.gov/pubmed/33613170 http://dx.doi.org/10.1159/000511750

Ejemplares similares

Cytomegalovirus Enterocolitis in a Patient with Refractory Immune-Related Colitis
por: Furuta, Yoki, et al.
Publicado: (2020)

Immune checkpoint inhibition-related colitis: symptoms, endoscopic features, histology and response to management
por: Geukes Foppen, Marnix H, et al.
Publicado: (2018)

When is an Assay of Cytomegalovirus Antigenemia Useful in Detecting Cytomegalovirus Colitis?
por: Kim, Kyeong Ok
Publicado: (2015)

T-cell immune response against cytomegalovirus in peripheral blood and colonic mucosa from ulcerative colitis and Crohn's disease patients
por: Nam, Seung-Joo, et al.
Publicado: (2018)

The Cumulative Colectomy Rate in Patients with Cytomegalovirus-Positive Ulcerative Colitis
por: Ozturk, Kadir, et al.
Publicado: (2015)

Reply: Careful Assessment Is Needed in Patients with Ulcerative Colitis with Evidence of Cytomegalovirus Reactivation
por: Kim, You Sun, et al.
Publicado: (2015)

JAK inhibitor, a new player for treatment-refractory microscopic colitis
por: Druez, Anne, et al.
Publicado: (2023)

Decision-making in surgical neonatal necrotizing enterocolitis
por: Wiwanitkit, Viroj
Publicado: (2009)

Cytomegalovirus Viremia, Pneumonitis, and Tocilizumab Therapy
por: van Duin, David, et al.
Publicado: (2011)

Everolimus and/or Nivolumab-Associated Cytomegalovirus Colitis in a Patient with Metastatic Renal Cell Carcinoma
por: Ismayilov, Rashad, et al.
Publicado: (2022)

Necrotising enterocolitis—a community-acquired infectious disease?
por: Huppertz, Hans-Iko, et al.
Publicado: (1992)

Cytomegalovirus-Related Hemophagocytic Lymphohistiocytosis after Renal Transplantation
por: Anandh, Urmila, et al.
Publicado: (2022)

Cecal Hematoma Associated with Suspected Necrotizing Enterocolitis in a Neonate
por: Mirza, M. Bilal, et al.
Publicado: (2019)

Cytomegalovirus Enterocolitis secondary to experimental COVID-19 therapy
por: Geisen, Will R., et al.
Publicado: (2020)

Passage of intestinal casts—An unusual presentation of Cytomegalovirus enterocolitis
por: Limthanetkul, Nisakorn, et al.
Publicado: (2021)

Direct and indirect costs of allergic and non‐allergic rhinitis in the Netherlands
por: Avdeeva, Klementina S., et al.
Publicado: (2020)

Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report
por: Corrigan, Margaret, et al.
Publicado: (2019)

The Role of Abdominal Surgery in Refractory Immune Checkpoint Inhibitor Enterocolitis: A Case Report
por: Verhé, Manon, et al.
Publicado: (2023)

Refractory hyperkalemia related to heparin abuse
por: Bawaskar, Himmatrao S., et al.
Publicado: (2014)

Successful treatment of steroid-refractory immune thrombocytopenia with alemtuzumab
por: Jung, Chul Won, et al.
Publicado: (2016)

New synergistic efficacy of combination of romiplostim and steroid in refractory immune thrombocytopenia patients
por: Yoon, Jun Seok, et al.
Publicado: (2018)

Microphthalmia and microcornea: In congenital cytomegalovirus
por: P, Kava Maina, et al.
Publicado: (2009)

Disseminated cytomegalovirus-associated hemophagocytic lymphohistiocytosis in an elderly patient
por: Jain, Preetesh, et al.
Publicado: (2016)

Cytomegalovirus infection in critically ill patients with COVID-19
por: Niitsu, Takayuki, et al.
Publicado: (2021)

Cytomegalovirus Reactivation in Critically-ill COVID-19 Patients
por: Talan, Leyla, et al.
Publicado: (2022)

High rate of complete responses to immune checkpoint inhibitors in patients with relapsed or refractory Hodgkin lymphoma previously exposed to epigenetic therapy
por: Falchi, Lorenzo, et al.
Publicado: (2016)

Anticipating implementation of colorectal cancer screening in The Netherlands: a nation wide survey on endoscopic supply and demand
por: van Turenhout, Sietze T, et al.
Publicado: (2012)

Cytomegalovirus Colitis in Immunocompetent Patients
por: Inayat, Faisal, et al.
Publicado: (2016)

Cytomegalovirus colitis in immunocompetent patients
por: Park, Jae Ho, et al.
Publicado: (2018)

A Rare Immune-Related Mesenteric and retroperitoneal serositis in a Multi-Refractory Hodgkin Lymphoma Patient Successfully Treated with Chylolymphostatic Surgery
por: D’Addona, Matteo, et al.
Publicado: (2023)

Observational study of cytomegalovirus from breast milk and necrotising enterocolitis
por: Patel, Ravi Mangal, et al.
Publicado: (2020)

Cytomegalovirus haemorrhagic enterocolitis associated with severe infection with COVID-19
por: Carll, Warren C, et al.
Publicado: (2021)

Multiple thrombosis associated with Cytomegalovirus enterocolitis in an immunocompetent patient: a case report
por: Kamatani, Kaisei, et al.
Publicado: (2021)

Cytomegalovirus proteins, maternal pregnancy cytokines, and their impact on neonatal immune cytokine profiles and acute lymphoblastic leukemogenesis in children
por: Wiemels, Joseph L., et al.
Publicado: (2022)

Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T‐cell lymphoma
por: Pro, Barbara, et al.
Publicado: (2016)

Clinical responses in pediatric patients with relapsed/refractory leukemia treated with azacitidine and venetoclax
por: Niswander, Lisa M., et al.
Publicado: (2023)

Cardiac complications in relapsed and refractory multiple myeloma patients treated with carfilzomib
por: Atrash, S, et al.
Publicado: (2015)

Microbiome analysis reveals that Ralstonia is responsible for decreased renal function in patients with ulcerative colitis
por: Kim, Jung Min, et al.
Publicado: (2021)

Food Protein‐Induced Enterocolitis Syndrome in South Tyrol 2012–2016: a population‐based study
por: Giusti, M., et al.
Publicado: (2019)

An exceptional response to nivolumab in relapsed and refractory malignant mesothelioma
por: Talreja, Vikas T., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8157lbasd1fe1fi5ndf2lt4tn4